Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Epidemiology
Published in: European Journal of Epidemiology 9/2015

01-09-2015 | META-ANALYSIS

Body mass index, abdominal fatness and the risk of gallbladder disease

Authors: Dagfinn Aune, Teresa Norat, Lars J. Vatten

Published in: European Journal of Epidemiology | Issue 9/2015

Login to get access

Abstract

Epidemiological studies have indicated a positive association between adiposity and gallbladder disease risk, however, the shape of the dose–response relationship and differences between overall and abdominal adiposity remains to be clarified. We conducted a systematic review and dose–response meta-analysis of cohort studies of body mass index (BMI), waist circumference and waist-to-hip ratio and risk of gallbladder disease. PubMed and Embase databases were searched up to January 9th 2015. Summary relative risks were calculated using a random effects model. Seventeen prospective studies of BMI and gallbladder disease risk with 55,670 cases among 1,921,103 participants were included. The summary relative risk (RR) for a 5 unit increment in BMI was 1.63 (95 % CI 1.49–1.78, I2 = 98 %). There was evidence of a nonlinear association overall and among women, p nonlinearity < 0.0001, but not among men, p nonlinearity = 0.99, with a slight flattening of the curve at very high BMI levels (BMI 40–45), however, the risk of gallbladder disease increased almost twofold even within the “normal” BMI range. The summary RR for a 10 cm increase in waist circumference was 1.46 (95 % CI 1.24–1.72, I2 = 98 %, n = 5) and for a 0.1 unit increment in waist-to-hip ratio was 1.44 (95 % CI 1.26–1.64, I2 = 92 %, n = 4). Associations were attenuated, but still significant, when BMI and abdominal adiposity measures were mutually adjusted. Our results confirm a positive association between both general and abdominal fatness and the risk of gallbladder disease. There is an almost twofold increase in the risk even within the “normal” BMI range, suggesting that even moderate increases in BMI may increase risk.
Appendix
Available only for authorised users
Literature
1.
Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound. 1999;27:1–7.CrossRefPubMed
2.
3.
Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20:981–96.CrossRefPubMed
4.
Zatonski WA, La VC, Przewozniak K, Maisonneuve P, Lowenfels AB, Boyle P. Risk factors for gallbladder cancer: a Polish case-control study. Int J Cancer. 1992;51:707–11.CrossRefPubMed
5.
6.
Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11.CrossRefPubMed
7.
Layde PM, Vessey MP, Yeates D. Risk factors for gall-bladder disease: a cohort study of young women attending family planning clinics. J Epidemiol Community Health. 1982;36:274–8.PubMedCentralCrossRefPubMed
8.
Petitti DB, Sidney S. Obesity and cholecystectomy among women: implications for prevention. Am J Prev Med. 1988;4:327–30.PubMed
9.
Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55:652–8.PubMed
10.
Kato I, Nomura A, Stemmermann GN, Chyou PH. Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors. Dig Dis Sci. 1992;37:784–90.CrossRefPubMed
11.
Grodstein F, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ. A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors. Obstet Gynecol. 1994;84:207–14.PubMed
12.
Moerman CJ, Berns MP, Smeets FW, Kromhout D. Regional fat distribution as risk factor for clinically diagnosed gallstones in middle-aged men: a 25-year follow-up study (the Zutphen Study). Int J Obes Relat Metab Disord. 1994;18:435–9.PubMed
13.
Sahi T, Paffenbarger RS Jr, Hsieh CC, Lee IM. Body mass index, cigarette smoking, and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni. Am J Epidemiol. 1998;147:644–51.CrossRefPubMed
14.
Boland LL, Folsom AR, Rosamond WD. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study. Ann Epidemiol. 2002;12:131–40.CrossRefPubMed
15.
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study of abdominal adiposity and gallstone disease in US men. Am J Clin Nutr. 2004;80:38–44.PubMed
16.
Gonzalez-Perez A. Garcia Rodriguez LA. Gallbladder disease in the general population: association with cardiovascular morbidity and therapy. Pharmacoepidemiol Drug Saf. 2007;16:524–31.CrossRefPubMed
17.
Williams PT. Independent effects of cardiorespiratory fitness, vigorous physical activity, and body mass index on clinical gallbladder disease risk. Am J Gastroenterol. 2008;103:2239–47.PubMedCentralCrossRefPubMed
18.
Festi D, Dormi A, Capodicasa S, et al. Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol. 2008;14:5282–9.PubMedCentralCrossRefPubMed
19.
Banim PJ, Luben RN, Bulluck H, et al. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). Eur J Gastroenterol Hepatol. 2011;23:733–40.CrossRefPubMed
20.
21.
Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58:2133–41.CrossRefPubMed
22.
Chen JY, Hsu CT, Liu JH, Tung TH. Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan. BMC Gastroenterol. 2014;14:83.PubMedCentralCrossRefPubMed
23.
Reeves GK, Balkwill A, Cairns BJ, Green J, Beral V. Hospital admissions in relation to body mass index in UK women: a prospective cohort study. BMC Med. 2014;12:45.PubMedCentralCrossRefPubMed
24.
Sichieri R, Everhart JE, Roth HP. Low incidence of hospitalization with gallbladder disease among blacks in the United States. Am J Epidemiol. 1990;131:826–35.PubMed
25.
Katsika D, Tuvblad C, Einarsson C, Lichtenstein P, Marschall HU. Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study. J Intern Med. 2007;262:581–7.CrossRefPubMed
26.
Liu B, Balkwill A, Spencer E, Beral V. Relationship between body mass index and length of hospital stay for gallbladder disease. J Public Health (Oxf). 2008;30:161–6.CrossRef
27.
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut. 2006;55:708–14.PubMedCentralCrossRefPubMed
28.
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Macronutrients and insulin resistance in cholesterol gallstone disease. Am J Gastroenterol. 2008;103:2932–9.CrossRefPubMed
29.
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.CrossRefPubMed
30.
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.PubMedCentralCrossRefPubMed
31.
Park M, Song DY, Je Y, Lee JE. Body mass index and biliary tract disease: a systematic review and meta-analysis of prospective studies. Prev Med. 2014;65:13–22.CrossRefPubMed
32.
Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581–6.CrossRefPubMed
33.
Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med. 1989;321:563–9.CrossRefPubMed
34.
Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA. Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med. 1999;130:471–7.CrossRefPubMed
35.
Misciagna G, Leoci C, Guerra V, et al. Epidemiology of cholelithiasis in southern Italy. Part II: risk factors. Eur J Gastroenterol Hepatol. 1996;8:585–93.CrossRefPubMed
36.
Etminan M, Delaney JA, Bressler B, Brophy JM. Oral contraceptives and the risk of gallbladder disease: a comparative safety study. CMAJ. 2011;183:899–904.PubMedCentralCrossRefPubMed
37.
Strom BL, Tamragouri RN, Morse ML, et al. Oral contraceptives and other risk factors for gallbladder disease. Clin Pharmacol Ther. 1986;39:335–41.CrossRefPubMed
38.
Kurata JH, Marks J, Abbey D. One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease. Dig Dis Sci. 1991;36:1110–5.CrossRefPubMed
39.
Halldestam I, Kullman E, Borch K. Incidence of and potential risk factors for gallstone disease in a general population sample. Br J Surg. 2009;96:1315–22.CrossRefPubMed
40.
41.
Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–9.PubMed
42.
Bagnardi V, Zambon A, Quatto P, Corrao G. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol. 2004;159:1077–86.CrossRefPubMed
43.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefPubMed
44.
45.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.CrossRefPubMed
46.
47.
World Cancer Research Fund/American Insitute for Cancer Research. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
48.
Hendel HW, Hojgaard L, Andersen T, et al. Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intra-abdominal fat masses in obese non-diabetic subjects. Int J Obes Relat Metab Disord. 1998;22:294–302.CrossRefPubMed
49.
50.
Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest. 1977;59:828–40.PubMedCentralCrossRefPubMed
51.
52.
Grundy SM, Metzger AL, Adler RD. Mechanisms of lithogenic bile formation in American Indian women with cholesterol gallstones. J Clin Invest. 1972;51:3026–43.PubMedCentralCrossRefPubMed
53.
Chen Q, Amaral J, Biancani P, Behar J. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity. Gastroenterology. 1999;116:678–85.CrossRefPubMed
54.
Sari R, Balci MK, Coban E, Karayalcin U. Sonographic evaluation of gallbladder volume and ejection fraction in obese women without gallstones. J Clin Ultrasound. 2003;31:352–7.CrossRefPubMed
55.
Mathus-Vliegen EM, Van Ierland-Van Leeuwen ML, Terpstra A. Determinants of gallbladder kinetics in obesity. Dig Dis Sci. 2004;49:9–16.CrossRefPubMed
56.
Preis SR, Massaro JM, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring). 2010;18:2191–8.CrossRef
57.
Jamal MM, Yoon EJ, Vega KJ, Hashemzadeh M, Chang KJ. Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol. 2009;15:5274–8.PubMedCentralCrossRefPubMed
58.
Shebl FM, Andreotti G, Rashid A, et al. Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer. 2010;103:115–9.PubMedCentralCrossRefPubMed
59.
Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004;80:1–2.PubMed
Metadata
Title
Body mass index, abdominal fatness and the risk of gallbladder disease
Authors
Dagfinn Aune
Teresa Norat
Lars J. Vatten
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 9/2015
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-015-0081-y

Other articles of this Issue 9/2015

European Journal of Epidemiology 9/2015 Go to the issue

LETTER TO THE EDITOR

The use of fecal samples for studying human obesity

CARDIOVASCULAR DISEASE

Fruit intake and cardiovascular disease mortality in the UK Women’s Cohort Study

METHODS

The detection of vector-borne-disease-related DNA in human stool paves the way to large epidemiological studies

DIALOGUE

The researcher and the consultant: from testing to probability statements

Reply

Obesity and stools, the “emperor’s new clothing” paradigm

NEURO-EPIDEMIOLOGY

Alcohol consumption and risk of dementia up to 27 years later in a large, population-based sample: the HUNT study, Norway